Skip to main content
. Author manuscript; available in PMC: 2021 Apr 30.
Published in final edited form as: Patient Educ Couns. 2019 Sep 9;103(2):266–275. doi: 10.1016/j.pec.2019.09.009

Table 2.

Subgroup Analyses.

Variable No. of studies Mean A1C Reduction 99% Confidence Level Cochrane Q; P Value I^2
Duration of intervention
 ≤6 months 7 −0.274 −0.510, −0.039 17.713 66.126
0.007
 >6 months 11 −0.221 −0.394, −0.048 11.533 13.295
.317
Initial A1C
 ≥8.5 9 −0.219 −0.673, 0.235 4.145 51.744
.126
 > 8.5 9 −0.236 −0.446, −0.026 27.220 63.262
.002
Interventionist
 Solo interventionist 10 −0.199 −0.379, −0.018 9.885 8.954
0.360
 Team approach 8 −0.295 −0.505, −0.085 18.573 62.310
0.010
Mode of DSME delivery
 Individual 6 −0.422 −0.618, −0.227 7.935 36.988
0.160
 Group 5 −0.172 −0.379, 0.035 2.788 0.000
0.594
 Combination 7 −0.137 −0.319, 0.044 7.878 23.837
0.247